Prognosis is determined by tumor stage, resectability, histologic grade, proliferation index, and size.

In an analysis of the surveillance, epidemiology, and end results database, the overall survival for the localized disease was estimated to be 110 months, compared to a significantly lower survival for those patients with regionally spread and metastatic disease with 59 and 35 months respectively.